Lexapro, also known by its generic name escitalopram, was first approved by the U.S. Food and Drug Administration (FDA) in 2002 [1]. It is a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder and generalized anxiety disorder [2].
Who developed Lexapro?
Lexapro was developed by Lundbeck and Forest Laboratories [3].
What are the patents for Lexapro?
The original patents for Lexapro have expired, allowing for the development of generic versions [4]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Lexapro [5].
How does Lexapro work?
Lexapro works by increasing the levels of serotonin in the brain [2]. Serotonin is a neurotransmitter that helps regulate mood and emotions [2]. By increasing serotonin, Lexapro can help alleviate symptoms of depression and anxiety [2].
What are the side effects of Lexapro?
Common side effects of Lexapro can include nausea, insomnia, ejaculation disorder, fatigue, and increased sweating [2]. Serious side effects are rare but can occur, such as an increased risk of suicidal thoughts or behavior, especially in young adults and children [2].
When does Lexapro patent expiration allow for generics?
The primary patents for Lexapro have expired, paving the way for generic escitalopram to become available [4]. DrugPatentWatch.com provides detailed information on drug patent expirations [5].